期刊文献+

帕司烟肼片中间氨基酚和游离肼的检测

Determination of 3-aminophenol and Free Hydrazine in Pasiniazid Tablets
暂未订购
导出
摘要 目的:建立帕司烟肼片中间氨基酚和游离肼的HPLC测定方法。方法:间氨基酚色谱柱:Agilent ZORBAX SB-Aq(4.6 mm×250 mm,5μm);流动相:甲醇-10%四丁基氢氧化铵溶液-0.05 mol·L^(-1)磷酸二氢钠(100∶2∶900);检测波长为220 nm;游离肼色谱柱:Diamonsil Plus C(4.6 mm×150 mm,5μm);流动相:0.1%乙二胺四乙酸二钠-乙腈(31∶69);检测波长为310 nm。结果:间氨基酚和游离肼的线性范围分别为0.1010~20.19μg·m L^(-1)和0.2590~51.80μg·m L^(-1)(r≥0.9999),检测限分别为0.1 ng、0.04 ng,平均回收率分别为99.39%、99.16%(RSD≤1.0%,n=8)。结论:该方法专属性好、操作简便、快速准确,可用于帕司烟肼片中间氨基酚和游离肼的的检测。 Objective:To establish an HPLC method for determination of 3-aminophenol and free hydrazine in Pasiniazid tablets.Methods:3-Aminophenol The eluate obtained was analyzed by HPLC method with Agilent ZORBAX SB-Aq(250 mm×4.6 mm,5μm),using methanol-10%Tetrabutylammonium hydroxide-0.05 mol·LNa HPObuffer(100∶2∶900)as mobile phase,and the detection wavelength was set at 220 nm.Free hydrazine The eluate obtained was analyzed by HPLC method with Diamonsil Plus C_(18)(150 mm×4.6 mm,5μm),using 0.1%EDTA-acetonitrilr(30∶70)as mobile phase,and the detection wavelength was set at 310 nm.Results:3-aminophenol and free hydrazine showed good linearity in the ranges of 0.1010-20.19μg·mL^(-1),0.2590-51.80μg·mL^(-1)(r≥0.9999)respectively.The detection limit were 0.1 ng、0.04 ng respectively.The average recovery values values of 3-aminophenol and free hydrazine of were99.39%、99.16%(RSD≤1.0%,n=8)respectively.Conclusion:The method is simple with high accuracy and reproducible,which can be used for the determination of 3-aminophenol and free hydrazine in Pasiniazid tablets.
作者 刘志辉 LIU Zhi-hui(The Food and Drug Control of Meizhou Institute,Guangdong Meizhou 514071,China)
出处 《中国药物评价》 2022年第5期395-398,共4页 Chinese Journal of Drug Evaluation
关键词 帕司烟肼片 间氨基酚 游离肼 高效液相色谱(HPLC) Pasiniazid tablets 3-aminophenol Free hydrazine High performance liquid chromatography(HPLC)
  • 相关文献

参考文献5

二级参考文献25

  • 1杨德柱,李文清,王开平,隋广志,隋凤君.高效液相色谱法测定异烟肼固体制剂血药浓度[J].黑龙江医药,1996,9(2):68-69. 被引量:3
  • 2国家药典委员会.中国药典(二部)[S].北京:化学工业出版社,2010:附录71.
  • 3ICH.Q3A(R2):Impurities in new drug substances?[EB/OL].http://www,ich.org/LOB/media/MEDIA422,pdf,2006 -10 -25.
  • 4国家食品药品监督管理局.化学药物原料药制备和结构确证研究的技术指导原则(2005)[EB/OL].http://www.sda.gov.cn/gsz05106/02.pdf,2005-03-18.
  • 5国家食品药品监督管理局.化学药物杂质研究的技术指导原则(2005)[EB/OL].http://www.sds.gov.cn/gsz05106/03.pdf,2005-03-18.
  • 6Syeheva TP,Pavlova TN,Shchukina MN.Synthesis of isoniazid from 4-cyanopyridine[J].Pharma Chem J,1972:6:696-698.
  • 7Hemant B,Saranjit S,Sanjay V,et al.LC and LC-MS study of stress decompesition behaviour of isoniazid and establishment of validated stability -indicating assay method[J].J Pharm Biom Anal,2007:43:1213 -1220.
  • 8Hung-Cheh C,Long-Jin L.Photolysis of isoniazid[J].J Chin Chem Society,1978:25:125-130.
  • 9WHO.多来源(仿制)药品指导原则附件8-药品质量信息介绍(PQIF)[EB/OL].http://www.who.int/prequal/chinese_de-fault.htm.2010-05-18.
  • 10李正化.药物化学[M].北京:人民卫生出版社,1993.409-411.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部